Advances in chemotherapy and targeted therapies have improved survival in cancer
patients with an increase of the incidence of newly diagnosed brain metastases (BMs) …

Oligometastatic non-small cell lung cancer (NSCLC) describes an intermediate stage of
NSCLC between localized and widely-disseminated disease. This stage of NSCLC is …

The number of patients who develop metastatic brain lesions is increasing as the diagnosis
and treatment of systemic cancers continues to improve, resulting in longer patient survival …

Patients with brain metastases (BrM) from renal cell carcinoma and their outcomes are not
well characterized owing to frequent exclusion of this population from clinical trials. We …

OBJECTIVE Resection of brain metastases (BMs) may be associated with increased risk of
leptomeningeal disease (LMD). This study examined rates and predictors of LMD, including …

Simple Summary Brain metastases are of increasing concern in the management of cancer
patients. New systemic treatment options like specific targeting agents or immune …

Purpose Postoperative stereotactic radiosurgery (SRS) has less detrimental effect on
cognition and quality of life compared with whole brain radiation therapy (WBRT) and is …

Background Little evidence has been generated for how best to manage patients with non-
small-cell lung cancer (nsclc) presenting with rarer clinical scenarios, including …

Despite complete surgical resection brain metastases are at significant risk of local
recurrence without additional radiation therapy. Traditionally, the addition of postoperative …

Metastatic tumours in the brain now represent one of the leading causes of death from
cancer. Current treatments are largely ineffective owing to the combination of late diagnosis …